Europe Breast Biopsy Devices Market, By Product (Biopsy Needles, Guidance Systems, Biopsy Tables, Localization Wires, Assay Kits, Liquid Biopsy Instruments, Others), Type (Needle Breast Biopsy, Open Surgical Breast Biopsy, Liquid Breast Biopsy, Other Biomarkers), Guidance (Image-Guided Biopsy, Liquid Biopsy, Other Guidance Techniques), Application (Early Cancer Screening, Therapy Selection, Treatment Monitoring, Recurrence Monitoring), Country (Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, Rest of Europe) - Industry Trends and Forecast to 2028
Europe breast biopsy devices market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with the CAGR of 6.98% in the forecast period of 2021 to 2028 and is expected to reach 318.81 million by 2028. The increase in inclination towards image-guided needle biopsies and minimally invasive biopsies across the globe is escalating the growth of the breast biopsy devices market.
A breast biopsy refers to a testing process of breast cancer or other breast related disorders through extraction of the breast cells or breast tissues. It is extensively utilized to diagnose uncharacteristic lump in the breast of female patients. Breast biopsy is also used for the detection of abnormal changes in the nipple including scaling, crusting of the skin or congealing.
The increase in prevalence of breast cancer among females globally and the growth in awareness regarding the breast cancer screening programs are the major factors driving the breast biopsy devices market. The increasing enhancement in the products, their approval and launches and acceptance of advanced technology also influence the market. Additionally, improved reimbursement scenario and the rise in demand for non-invasive procedures and minimally invasive procedures among population accelerate the growth of breast biopsy devices market. Furthermore, technological advancement, introduction of promising clinical trials and liquid biopsy, rise in investment by profit and non-profit organization and emerging economies extend profitable opportunities to the market players in the forecast period of 2021 to 2028.
On the other hand, implementation of stringent regulations associated with the approval of procedures, high cost of procedures and product recalls are factors expected to obstruct the market growth. The concerns related with the risk of infections due to the utilization of biopsy needles, specific targeted population are projected to challenge the breast biopsy devices market.
This breast biopsy devices market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on breast biopsy devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Breast Biopsy Devices Market Scope and Market Size
Breast biopsy devices market is segmented on the basis of product, type, guidance and application. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of product, the breast biopsy devices market is segmented into biopsy needles, guidance systems, biopsy tables, localization wires, assay kits, liquid biopsy instruments and others.
- On the basis of type, the breast biopsy devices market is segmented into needle breast biopsy, open surgical breast biopsy, liquid breast biopsy and other biomarkers.
- On the basis of guidance, the breast biopsy devices market is segmented into image-guided biopsy, liquid biopsy and other guidance techniques.
- On the basis of application, the breast biopsy devices market is segmented into early cancer screening, therapy selection, treatment monitoring and recurrence monitoring.
Breast Biopsy Devices Market Country Level Analysis
Breast biopsy devices market is analyzed and market size insights and trends are provided by country, product, type, guidance and application as referenced above.
The countries covered in the breast biopsy devices market report are the Germany, U.K., France, Italy, Spain, Switzerland, Netherlands, Belgium, Russia, Turkey and Rest of Europe.
Italy dominates the breast biopsy devices market in the Europe region due to the large number of female population.
The country section of the breast biopsy devices market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
Breast biopsy devices market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for breast biopsy devices market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the breast biopsy devices market. The data is available for historic period 2010-2019.
Competitive Landscape and Breast Biopsy Devices Market Share Analysis
Breast biopsy devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to breast biopsy devices market.
The major players covered in the breast biopsy devices market report are Stryker, Devicor Medical Products Inc., Hologic, Inc., Leica Biosystems Nussloch GmbH, BD., ARGON MEDICAL., Cook, Ethicon, Danaher, United Medical Systems Inc., and Olympus Corporation among others. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.